In vivo cell engineering using a bone marrow organoid
- Institution
- UNIVERSITY OF SOUTHERN CALIFORNIA, CA
- Principal investigator
- David T Scadden
- Funding
- $674K
- Duration
- 2025–2030
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY/ABSTRACT This project tests a bioinstructive material capable of forming bone and bone marrow in a localized, easily accessible subcutaneous site as a delivery portal for anti-HIV genetic engineering constructs. The larger goal is to enable genetic engineering of blood progenitor and stem cells without requiring hematopoietic stem cell transplantation and without incurring the liabilities of systemically delivered gene modifying vectors. By enabling easy access to a subcutaneous bone marrow organoid, small concentrations of gene engineering vectors can be locally administered reducing the cost of goods and likelihood of modifying other organs. The organoid will be tuned to produce specific subsets of cells appropriate for the varying anti-HIV constructs in Projects 1 and 2. The ability of this strategy to generate HIV-1 resistant stem and progenitor cells will be tested in humanized mice and non-human primates in close collaboration with investigators in this project and the larger program.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF SOUTHERN CALIFORNIA
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Massachusetts General HospitalNot yet scored
PROJECT 1: Modulating blood cell heterogeneity to reduce cardiovascular inflammation
David T Scadden · $355K · 2018–2030
- NIH · Massachusetts General HospitalNot yet scored
Functional consequences of stem and progenitor cell heterogeneity
David T Scadden · $2.5M · 2017–2028
- NIH · Massachusetts General HospitalNot yet scored
Administrative Core
David T Scadden · $25K · 2017–2028